Unexpected Interruptions in the Inhaled Epoprostenol Delivery System: Incidence of Adverse Sequelae and Therapeutic Consequences in Critically Ill Patients

Inhaled epoprostenol is a continuously delivered selective pulmonary vasodilator that is used in patients with refractory hypoxemia, right heart failure, and postcardiac surgery pulmonary hypertension. Published data suggest that inhaled epoprostenol administration via vibrating mesh nebulizer syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Block, Jason M., Madhok, Jai, Owyang, Clark G., Merriman, Kristen R., Ruoss, Stephen J., Rao, Vidya K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522871/
https://www.ncbi.nlm.nih.gov/pubmed/34671745
http://dx.doi.org/10.1097/CCE.0000000000000548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522871/
https://www.ncbi.nlm.nih.gov/pubmed/34671745
http://dx.doi.org/10.1097/CCE.0000000000000548

Ejemplares similares